PolyADP-ribose-mediated regulation of p53 complexed with topoisomerase I following ionizing radiation

Carcinogenesis

Volumn 20, Issue 8, 1999, Pages 1439-1443

  Smith, Heather M ^a   Grosovsky, Andrew J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA TOPOISOMERASE; ENZYME ANTIBODY; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN P53;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IONIZING RADIATION; LYMPHOBLASTOID CELL; PRIORITY JOURNAL;

DNA DAMAGE; DNA TOPOISOMERASES, TYPE I; GAMMA RAYS; HUMANS; POLY(ADP-RIBOSE) POLYMERASES; PRECIPITIN TESTS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032818432     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.8.1439     Document Type: Article

References (25)

1. Kastan, M.B., Zhan, Q., El-Deiry, W.S., Carrier, F., Jacks, T., Walsh, W.V., Plunkett, B.S., Vogelstein, B. and Fornace, A.J. Jr (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71, 587-597.
2. Papathanasiou, M.A., Kerr, N.C., Robbins, J.H., McBride, O.W., Alamo, I.J. Jr, Barrett, S.F., Hickson, I.D. and Fornace, A.J. Jr (1991) Induction by ionizing radiation of the gadd45 gene in cultured human cells: lack of mediation by protein kinase C. Mol. Cell. Biol., 11, 1009-1016.
3. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W. and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
4. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. and Craig, R.W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311.
5. Maltzman, W. and Czyzyk, L. (1984) UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol., 4, 1689-1694.
6. Blagosklonny, M.V. (1997) Loss of function and p53 protein stabilization. Oncogene, 15, 1889-1893.
7. Milczarek, G.J., Martinez, J. and Bowden, G.T. (1997) p53 phosphorylation: biochemical and functional consequences. Life Sci., 60, 1-11.
8. Maki, C.G., Huibregtse, J.M. and Howley, P.M. (1996) In vivo ubiquination and proteasome-mediated degradation of p53. Cancer Res., 56, 2649-2654.
9. Wesierska-Gadek, J., Schmid, G. and Cerni, C. (1996) ADP-ribosylation of wild-type p53 in vitro: binding of p53 protein to specific consensus sequence prevents its modification. Biochem. Biophys. Res. Commun., 224, 96-102.
10. Vaziri, H., West, M.D., Allsopp, R.C., Davison, T.S., Wu, Y.-S., Arrowsmith, C.H., Poirier, G.G. and Benchimol, S. (1997) ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J., 16, 6018-6033.
11. Malanga, M., Pleschke, J.M., Kleczkowska, H.E. and Althus, F.R. (1998) Poly(ADP-ribose) binds to specific domains of p53 and alters DNA binding functions. J. Biol. Chem., 273, 11839-11843.
12. Whitacre, C.M., Hashimoto, H., Tsai, M.L., Chatterjee, S., Berger, S.J. and Berger, N.A. (1995) Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences. Cancer Res., 55, 3697-3701.
13. r 85,000 proteolytic fragment. Cancer Res., 58, 5075-5078.
14. Gobert, C., Bracco, L., Rossi, F., Olivier, M., Tazi, J., Lavelle, F., Larsen, A.K. and Riou, J.-F. (1996) Modulation of DNA topoisomerase I activity by p53. Biochemistry, 35, 5778-5786.
15. Albor, A., Kaku, S. and Kulesz-Martin, M. (1998) Wild-type and mutant forms of p53 activate human topoisomerase I: a possible mechanism for gain of function mutants. Cancer Res., 58, 2091-2094.
16. Boothman, D.A., Fukunaga, N. and Wang, M. (1994) Down-regulation of topoisomerase I in mammalian cells following ionizing radiation. Cancer Res., 54, 4618-4626.
17. Liber, H.L. and Thilly, W.G. (1982) Mutation assay at the thymidine kinase locus in diploid human lymphoblasts. Mutat. Res., 94, 467-485.
18. Skopek, T.R., Liber, H.L., Penman, B.W. and Thilly, W.G. (1978) Isolation of a human lymphoblastoid line heterozygous at the thymidine kinase locus: possibility for a rapid human cell mutation assay. Biochem. Biophys. Res. Commun., 84, 411-416.
19. Xia, F., Wang, X., Wang, Y.H., Tsang, N.M, Yandell, D.W., Kelsey, K.T. and Liber, H.L. (1995) Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res., 55, 12-15.
20. 1 arrest in two closely related human lymphoblast cell lines that differ in p53 status. J. Biol. Chem., 270, 11033-11036.
21. Minford, J., Pommier, Y., Filipski, J., Kohn, K.W., Kerrigan, D., Mattern, M., Michaels, S., Schwartz, R. and Zwelling, L.A. (1986) Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II. Biochemistry, 25, 9-16.
22. Yu, Y., Li, C.-Y. and Little, J.B. (1997) Abrogation of p53 function by HPV16 E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells. Oncogene, 14, 1661-1667.
23. Ikai, K., Ueda, K., Fukushima, M., Nakamura, T. and Hayaishi, O. (1980) PolyADP-ribose synthesis, a marker of granulocyte differentiation. Proc. Natl Acad. Sci. USA, 77, 3682-3685.
24. De Murcia, G., Huletsky, A. and Poirier, G.G. (1988) Review: modulation of chromatin structure by poly(ADP-ribosyl)ation. Biochem. Cell. Biol., 66, 626-635.
25. Wang, J.C. (1985) DNA Topoisomerases. Annu. Rev. Biochem., 54, 665-697.